ArcScan, Inc. Signs Definitive Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technology Ltd.
Summary
The breakthrough technology from ArcScan, Inc. not only meets the unmet medical needs in the ophthalmic imaging field, but also leverages with our global product portfolio to significantly improve post-surgical results in premium IOLs and PIOL implantations." A mechanically controlled 50 MHz transducer scans the eye in an arc shaped motion with a curvature that approximates the anterior ocular surface. "The most advanced method for ICL sizing is to use the Insight 100 very-high-frequency digital ultrasound scanner to directly measure the area inside the eye, behind the iris where the lens will sit." ArcScan develops smart imaging technology and continually evolving ultrasound to provide ophthalmologists with new insights into the true anatomy of the anterior segment of the eye, including areas behind the iris. ArcScans mission is to enable better medicine in ophthalmology by driving improved outcomes in refractive, corneal, cataract, and glaucoma surgeries.